Model Medicines

company

About

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$4.10M
Industries
Artificial Intelligence,Biotechnology,Machine Learning,Medical,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale. Model Medicines harnesses AI and ML with its ActivPred AI Drug Discovery Platform to discover drugs that may be repositioned to serve as therapeutics to treat patients suffering from humankind’s toughest diseases.

The drugs that Model Medicines discovers can enter clinical trials in as little as several months.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4.10M
Model Medicines has raised a total of $4.10M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2021 Seed $4.10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Model Medicines is funded by 1 investors. Particle Accelerator Limited (ParticleX) are the most recent investors.
Investor Name Lead Investor Funding Round
Particle Accelerator Limited (ParticleX) Seed